Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2018 3
2019 3
2020 5
2021 14
2022 11
2023 9
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Microplastics and Nanoplastics in Atheromas and Cardiovascular Events.
Marfella R, Prattichizzo F, Sardu C, Fulgenzi G, Graciotti L, Spadoni T, D'Onofrio N, Scisciola L, La Grotta R, Frigé C, Pellegrini V, Municinò M, Siniscalchi M, Spinetti F, Vigliotti G, Vecchione C, Carrizzo A, Accarino G, Squillante A, Spaziano G, Mirra D, Esposito R, Altieri S, Falco G, Fenti A, Galoppo S, Canzano S, Sasso FC, Matacchione G, Olivieri F, Ferraraccio F, Panarese I, Paolisso P, Barbato E, Lubritto C, Balestrieri ML, Mauro C, Caballero AE, Rajagopalan S, Ceriello A, D'Agostino B, Iovino P, Paolisso G. Marfella R, et al. Among authors: scisciola l. N Engl J Med. 2024 Mar 7;390(10):900-910. doi: 10.1056/NEJMoa2309822. N Engl J Med. 2024. PMID: 38446676
miR-21 in Human Cardiomyopathies.
Surina S, Fontanella RA, Scisciola L, Marfella R, Paolisso G, Barbieri M. Surina S, et al. Among authors: scisciola l. Front Cardiovasc Med. 2021 Oct 27;8:767064. doi: 10.3389/fcvm.2021.767064. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34778418 Free PMC article. Review.
Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque.
Marfella R, Prattichizzo F, Sardu C, Paolisso P, D'Onofrio N, Scisciola L, La Grotta R, Frigé C, Ferraraccio F, Panarese I, Fanelli M, Modugno P, Calafiore AM, Melchionna M, Sasso FC, Furbatto F, D'Andrea D, Siniscalchi M, Mauro C, Cesaro A, Calabrò P, Santulli G, Balestrieri ML, Barbato E, Ceriello A, Paolisso G. Marfella R, et al. Among authors: scisciola l. Atherosclerosis. 2023 Aug;378:117180. doi: 10.1016/j.atherosclerosis.2023.06.971. Epub 2023 Jun 29. Atherosclerosis. 2023. PMID: 37422356
Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary.
Mascolo A, Di Napoli R, Balzano N, Cappetta D, Urbanek K, De Angelis A, Scisciola L, Di Meo I, Sullo MG, Rafaniello C, Sportiello L. Mascolo A, et al. Among authors: scisciola l. Front Cardiovasc Med. 2022 Sep 21;9:1010693. doi: 10.3389/fcvm.2022.1010693. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36211584 Free PMC article. Review.
Organ-specific biological clocks: Ageotyping for personalized anti-aging medicine.
Prattichizzo F, Frigé C, Pellegrini V, Scisciola L, Santoro A, Monti D, Rippo MR, Ivanchenko M, Olivieri F, Franceschi C. Prattichizzo F, et al. Among authors: scisciola l. Ageing Res Rev. 2024 Apr;96:102253. doi: 10.1016/j.arr.2024.102253. Epub 2024 Mar 4. Ageing Res Rev. 2024. PMID: 38447609 Review.
Tirzepatide prevents neurodegeneration through multiple molecular pathways.
Fontanella RA, Ghosh P, Pesapane A, Taktaz F, Puocci A, Franzese M, Feliciano MF, Tortorella G, Scisciola L, Sommella E, Ambrosino C, Paolisso G, Barbieri M. Fontanella RA, et al. Among authors: scisciola l. J Transl Med. 2024 Jan 29;22(1):114. doi: 10.1186/s12967-024-04927-z. J Transl Med. 2024. PMID: 38287296 Free PMC article.
Corrigendum: miR-21 in Human Cardiomyopathies.
Surina, Fontanella RA, Scisciola L, Marfella R, Paolisso G, Barbieri M. Surina, et al. Among authors: scisciola l. Front Cardiovasc Med. 2022 Apr 25;9:913429. doi: 10.3389/fcvm.2022.913429. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35548429 Free PMC article.
Evidence that tirzepatide protects against diabetes-related cardiac damages.
Taktaz F, Scisciola L, Fontanella RA, Pesapane A, Ghosh P, Franzese M, Tortorella G, Puocci A, Sommella E, Signoriello G, Olivieri F, Barbieri M, Paolisso G. Taktaz F, et al. Among authors: scisciola l. Cardiovasc Diabetol. 2024 Mar 30;23(1):112. doi: 10.1186/s12933-024-02203-4. Cardiovasc Diabetol. 2024. PMID: 38555463 Free PMC article.
48 results